Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Inhibitors of cholesterol biosynthesis under study at Pfizer

March 11, 1998

Lilly expands product options for Ligand

March 11, 1998

New ACAT-inhibitory malondiamido derivatives from Sanwa

March 10, 1998

First approval for RPR's new combination patch

March 10, 1998

Antithromboxane therapy leads to clinical benefit in type II diabetics

March 9, 1998

Droxia approved by FDA for sickle cell anemia

March 6, 1998

Mechanism of insulinotropic action of BTS-67582 explored in B-cells

March 5, 1998

New agents for lowering blood glucose and plasma triglycerides

March 5, 1998

Antidiabetic agents in development at Boehringer Mannheim

March 4, 1998

University of Alabama describes delta-EKLFs for hemoglobinopathies

March 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...